ANGLE plc (AGL.L) Research

ANGLE plc is a medical diagnostics firm that specializes in developing advanced products for cancer detection. Its flagship offering is the Parsortix cell separation system, engineered to isolate and collect circulating tumor cells (CTCs) from the bloodstream of patients with metastatic breast cancer. The company also provides the HyCEAD multiplex analysis system, which enables both routine and targeted analysis of DNA, RNA, or protein biomarkers. Founded in 1994, ANGLE plc is headquartered in Guildford, United Kingdom.

Market snapshot

Symbol
AGL.L
Price
$0.92
Day change
-5.64%
Market cap
$30.2M
P/E ratio
-2.13x
52-week range
0.85-17.445
Sector
Healthcare
Industry
Medical - Diagnostics & Research

Peer companies

  • Cizzle Biotechnology Holdings Plc (CIZ.L)
  • Cambridge Nutritional Sciences plc (CNSL.L)
  • Futura Medical plc (FUM.L)
  • Genedrive Plc (GDR.L)
  • GENinCode plc (GENI.L)
  • Oxford BioDynamics Plc (OBD.L)
  • OptiBiotix Health Plc (OPTI.L)
  • Proteome Sciences plc (PRM.L)

Open ANGLE plc (AGL.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.